Brief: Auris Medical Announces Completion Of Bentrio Conformity Assessment Procedure For Marketing In EU
May 25 (Reuters) - Auris Medical Holding Ltd EARS.O :
* AURIS MEDICAL ANNOUNCES COMPLETION OF BENTRIO CONFORMITY
ASSESSMENT PROCEDURE FOR MARKETING IN EU
* AURIS MEDICAL HOLDING LTD - MEETING ESSENTIAL REQUIREMENTS
FOR
MARKETING BENTRIO IN EUROPE UNDER CE MARK
* AURIS MEDICAL HOLDING LTD - ON TRACK FOR FIRST PRODUCT
LAUNCH IN
EUROPE TOWARDS END OF Q2 2021
Source text for Eikon: ID:nGNX65ySgR
Further company coverage: EARS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Altamira Therapeutics
See all newsBrief: Altamira Therapeutics Reports Full Year 2024 Results
Brief: Altamira Therapeutics Announces Transition From Nasdaq To OTC Markets
Brief: Altamira Therapeutics Provides Update On Nasdaq Listing
Brief: Altamira Therapeutics Provides Business Update And First Half 2024 Financial Results
Brief: Altamira Therapeutics Announces Pricing Of Up To $12.0 Mln Public Offering